SCHEMBL2579581

SCHEMBL2579581

CCOC(=O)[C@@H]1CC=C(c2nc(C)cs2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.40
CDK9 P50750 2/20 0.40
CCNT1 O60563 1/20 0.40
MAPK1 P28482 2/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 3/20 0.36
RAB9A P51151 2/20 0.36
RORC P51449 1/20 0.36
LIMK1 P53667 1/20 0.36
KMT2A Q03164 4/20 0.35
KDM4E B2RXH2 3/20 0.35
CLK1 P49759 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LGMN Q99538 1/20 0.35
MEN1 O00255 3/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2579579 1.00 PDK1 (0.40) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL14709506 0.88 CDK9 (0.39) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL14709494 0.81 CDK9 (0.44) CDK9CCNT1MAPK1TSHRMAPT
SCHEMBL2517575 0.81 TSHR (0.47) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL2583734 0.81 CDK9 (0.44) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL2517577 0.81 TSHR (0.47) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL2583738 0.81 CDK9 (0.44) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL2542243 0.80 MEN1 (0.46) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL2542240 0.80 MEN1 (0.46) PDK1CDK9CCNT1MAPK1ALOX15
SCHEMBL14697209 0.79 CDK9 (0.47) PDK1CDK9CCNT1MAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569319-B1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES HOFFMANN LA ROCHE (CH) 2014-09-24 EP disclosed
US-8513238-B2 Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes HOFFMANN-LA ROCHE INC. (US) 2013-08-20 US disclosed
EP-2569319-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES F.HOFFMANN-LA ROCHE AG (CH) 2013-03-20 EP disclosed
WO-2011141396-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES F. HOFFMANN-LA ROCHE AG (CH) 2011-11-17 WO disclosed
US-20110275801-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES HOFFMANN-LA ROCHE, INC. 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275801-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AVPR1A, AVPR1B, OXTR PDK1 2348/4885CDK9 3248/4885CCNT1 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.